Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholicliver disease.
June 2017 – World Journal of Gastroenterology (2017)
An Empirical Biomarker-Based Calculator for Cystic Index in a Model of Autosomal RecessivePolycystic Kidney Disease-The Nieto-Narayan Formula.
October 2016 – PLOS One (2016)
Late intervention with the small molecule BB3 mitigates postischemic kidney injury..
August 2016 – American Journal of Physiology – Renal Physiology (2016)
Acute injury in natural diet-induced fatty livers – a model for therapy development
August 2015 – Journal: Recent Patents on Biomarkers 2015
Sustained functional improvement by hepatocyte growth factor-like small molecule BB3 after focalcerebral ischemia in rats and mice
June 2015 – Journal of Cerebral Blood Flow & Metabolism (2015)
A Biomarker Cluster for Polycystic Kidney Disease: Correlation with Cystic Index
March 2015 – Recent Patents on Biomarkers 2015
Injectable microspheres for extended delivery of bioactive insulin and salicylic acid
February 2015 – Journal of Bioactive and Compatible Polymers 2015
The Lifetime Health Burden of Delayed Graft Function in Kidney Transplant Recipients in the United States
June 2018 – MDM Policy & Practice
Delayed Graft Function: The AKI of Kidney Transplantation
June 25 2018 – Journal: Nephron Clinical Practice
Improving the Supply and Quality of Deceased-Donor Organs for Transplantation.
May 2018 – N Engl J Med.
Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association
March 2018 – Circulation
Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment.
November 2017 – Nature Reviews Nephrology
The Economic Consequences of Acute Kidney Injury
April 2017 – Nephron Clinical Practice
Acute Kidney Injury in the Era of the AKI E-Alert.
December 2016 – The American Society of Nephrology
Acute kidney injury following cardiac surgery: current understanding and future directions
July 2016 – Critical Care
Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation.
October 2015 – International Society of Nephrology
ROCK and Rho: Promising therapeutic targets to ameliorate pulmonary fibrosis.
April 2015 – The American Journal of Pathology
Hospital-acquired acute kidney injury and hospital readmission: a cohort study
February 2015 – American Journal of Kidney Diseaes
Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury
September 2013 – Kidney International
Acute kidney injury
August 2012 – Lancet
Acute kidney injury: what’s the prognosis?
April 2011 – Nature Reviews Nephrology
Duration of acute kidney injury impacts long-term survival after cardiac surgery
October 2010 – Ann Thorac Surg.
The discovery of Hepatocyte Growth Factor (HGF) and its significance for cell biology, life sciences and clinical medicine
June 2010 – Proceedings of the Japan Academy. Series B Physical and Biological Sciences
Acute kidney injury predicts outcomes of non-critically ill patients
May 2009 – Mayo Clinic Proceedings
Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery.
May 2009 – Circulation
Preoperative risk factors for the development of acute renal failure in cardiac surgery
March 2007 – Brazilian Journal of Cardiovascular Surgery
Incidence and outcomes in acute kidney injury: a comprehensive population-based study
April 2007 – Journal of the American Society of Nephrology
Comparison of early renal function parameters for the prediction of 5-year graft survival after kidney transplantation
January 2007 – Nephrology Dialysis Transplantation
Hepatocyte growth factor: from diagnosis to clinical applications.
January 2003 – Clin Chim Acta
Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure
February 1999 – Kidney International
ANG-3777 Improves Outcomes in Patients with Delayed Graft Function: A Randomized, Double-Blind, Placebo Controlled Phase 2 Trial with 12-Month Follow-Up
Delayed Graft Function (DGF) in Kidney Transplantation Patients: An Analysis of Disease Burden
Impact of delayed graft function (DGF) on length of stay after a deceased donor kidney transplant
A Modified Ellipsoid Formula for Estimating Total Kidney Volume
Machine Learning and Glomerular Remodeling
Remodeling of the Glomerular Tuft in Proteinuric Kidney Disease